Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

Tissue-Type Plasminogen Activator

  • Manuel Yepes
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_101941

Synonyms

 PLAT;  tPA;  T-PA

Historical Background

Tissue-type plasminogen activator (tPA) is a serine proteinase that induces clot lysis by catalyzing the conversion of clot-bound plasminogen to plasmin. The history of tPA began with the identification in 1947 and successful extraction in 1952 of a plasminogen activator from animal tissues that was named fibrinokinase (Astrup and Stage 1952). In 1957 this activator was found in the brain, lung, heart, uterus, muscles, prostate, adrenal gland, testis, and ovaries, and in 1964 it was already known as tissue activator of plasminogen. The first purified form of human tPA was obtained from uterine tissue in 1979, and soon thereafter it was found to be identical to vascular plasminogen activator and blood plasminogen activator (Rijken et al. 1980; Pennica et al. 1983). These findings led to establish that the plasminogen activator found in blood corresponds to the vascular tPA released into the circulation by endothelial cells. Together,...

This is a preview of subscription content, log in to check access.

References

  1. An J, Haile WB, Wu F, Torre E, Yepes M. Tissue-type plasminogen activator mediates neuroglial coupling in the central nervous system. Neuroscience. 2014;257:41–8. doi:10.1016/j.neuroscience.2013.10.060.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Astrup T, Stage A. Isolation of a soluble fibrinolytic activator from animal tissue. Nature. 1952;170(4335):929. doi:10.1038/170929a0.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Collen D, Topol EJ, Tiefenbrunn AJ, Gold HK, Weisfeldt ML, Sobel BE, et al. Coronary thrombolysis with recombinant human tissue-type plasminogen-activator – a prospective, randomized, placebo-controlled trial. Circulation. 1984;70(6):1012–7.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Echeverry R, Wu J, Haile WB, Guzman J, Yepes M. Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. J Clin Invest. 2010;120(6):2194–205.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Levin EG, del Zoppo GJ. Localization of tissue plasminogen activator in the endothelium of a limited number of vessels. Am J Pathol. 1994;144(5):855–61.PubMedPubMedCentralGoogle Scholar
  6. Lijnen HR, Collen D. Strategies for the improvement of thrombolytic agents. Thromb Haemost. 1991;66(1):88–110.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Liu Z, Li Y, Zhang L, Xin H, Cui Y, Hanson LR, et al. Subacute intranasal administration of tissue plasminogen activator increases functional recovery and axonal remodeling after stroke in rats. Neurobiol Dis. 2012;45(2):804–9. doi:10.1016/j.nbd.2011.11.004.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Matsuo O, Rijken DC, Collen D. Thrombolysis by human-tissue plasminogen-activator and urokinase in rabbits with experimental pulmonary embolus. Nature. 1981;291(5816):590–1. doi:10.1038/291590a0.CrossRefPubMedPubMedCentralGoogle Scholar
  9. Muller CM, Griesinger CB. Tissue plasminogen activator mediates reverse occlusion plasticity in visual cortex. Nat Neurosci. 1998;1(1):47–53.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Pawlak R, Magarinos AM, Melchor J, McEwen B, Strickland S. Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior. NatNeurosci. 2003;6(2):168–74.Google Scholar
  11. Pennica D, Holmes WE, Kohr WJ, Harkins RN, Vehar GA, Ward CA, et al. Cloning and expression of human tissue-type plasminogen-activator cDNA in Escherichia-coli. Nature. 1983;301(5897):214–21. doi:10.1038/301214a0.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Polavarapu R, Gongora MC, Yi H, Ranganthan S, Lawrence DA, Strickland D, et al. Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit. Blood. 2007;109(8):3270–8.PubMedPubMedCentralCrossRefGoogle Scholar
  13. Qian Z, Gilbert ME, Colicos MA, Kandel ER, Kuhl D. Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature. 1993;361(6411):453–7.PubMedPubMedCentralCrossRefGoogle Scholar
  14. Rijken DC, Wijngaards G, Welbergen J. Relationship between tissue plasminogen-activator and the activators in blood and vascular wall. Thromb Res. 1980;18(6):815–30. doi:10.1016/0049-3848(80)90204-2.CrossRefPubMedPubMedCentralGoogle Scholar
  15. Sappino AP, Madani R, Huarte J, Belin D, Kiss JZ, Wohlwend A, et al. Extracellular proteolysis in the adult murine brain. JClinInvest. 1993;92(2):679–85.Google Scholar
  16. Shen LH, Xin H, Li Y, Zhang RL, Cui Y, Zhang L, et al. Endogenous tissue plasminogen activator mediates bone marrow stromal cell-induced neurite remodeling after stroke in mice. Stroke. 2011;42(2):459–64. doi:10.1161/STROKEAHA.110.593863.CrossRefPubMedPubMedCentralGoogle Scholar
  17. The National Institute of Neurological D, Stroke rt PASSG. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581–7.CrossRefGoogle Scholar
  18. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med. 1998;4(2):228–31.PubMedPubMedCentralCrossRefGoogle Scholar
  19. Weimar W, Stibbe J, Vanseyen AJ, Billiau A, Desomer P, Collen D. Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen-activator. Lancet. 1981;2(8254):1018–20.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Wu F, Wu J, Nicholson AD, Echeverry R, Haile WB, Catano M, et al. Tissue-type plasminogen activator regulates the neuronal uptake of glucose in the ischemic brain. J Neurosci Off J Soc Neurosci. 2012;32(29):9848–58. doi:10.1523/JNEUROSCI.1241-12.2012.CrossRefGoogle Scholar
  21. Wu F, Torre E, Cuellar-Giraldo D, Cheng L, Yi H, Bichler EK, et al. Tissue-type plasminogen activator triggers the synaptic vesicle cycle in cerebral cortical neurons. J Cereb Blood Flow Metab. 2015;35(12):1966–76. doi:10.1038/jcbfm.2015.155.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Yepes M. Tissue-type plasminogen activator is a modulator of the synaptic vesicle cycle. Neural Regen Res. 2016;11(2):212–3. doi:10.4103/1673-5374.177712.CrossRefPubMedPubMedCentralGoogle Scholar
  23. Yepes M, Sandkvist M, Wong MK, Coleman TA, Smith E, Cohan SL, et al. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood. 2000;96(2):569–76.PubMedPubMedCentralGoogle Scholar
  24. Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. JClinInvest. 2003;112(10):1533–40.Google Scholar
  25. Yepes M, Wu F, Torre E, Cuellar-Giraldo D, Jia D, Cheng L. Tissue-type plasminogen activator induces synaptic vesicle endocytosis in cerebral cortical neurons. Neuroscience. 2016;319:69–78. doi:10.1016/j.neuroscience.2016.01.046.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of NeurologyEmory UniversityAtlantaUSA
  2. 2.Division of NeurosciencesYerkes National Primate Research CenterAtlantaUSA